Quality of life and health economics: Where is the link?

Scandinavian Journal of Gastroenterology, Supplement

Volumn 31, Issue 221, 1996, Pages 33-36

  Jonsson B ^a  

^a STOCKHOLM SCHOOL OF ECONOMICS   (Sweden)

Author keywords

Clinical trial; Health economics; QOL

Indexed keywords

CONFERENCE PAPER; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; HEALTH ECONOMICS; HUMAN; PRIORITY JOURNAL; QUALITY OF LIFE; ARTICLE; ECONOMICS; HEALTH CARE COST; HEALTH CARE ORGANIZATION; HEALTH SERVICES RESEARCH; HEALTH SURVEY; METHODOLOGY; OUTCOME ASSESSMENT; QUALITY ADJUSTED LIFE YEAR;

COST-BENEFIT ANALYSIS; HEALTH CARE COSTS; HEALTH CARE RATIONING; HEALTH SERVICES RESEARCH; HEALTH STATUS INDICATORS; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); QUALITY OF LIFE; QUALITY-ADJUSTED LIFE YEARS;

EID: 0030470126     PISSN: 00855928     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365529609095553     Document Type: Conference Paper

References (12)

1. Bennett KJ, Torrance GW. Measuring health state preferences and utilities: rating scale, time trade-off, and standard gamble techniques. In: Spilker B, editor. Quality of Life and pharmacoeconomics in clinical trials. Second edition. Philadelphia: Lippincott-Raven Publishers, 1996:253-65.
2. Fanshel S, Bush JW. A health status index and its application to health-service outcomes. Operations Res 1970;18:1021-66.
3. Kaplan RM, Bush JW. Health status: types of validity for an index of well-being. Health Serv Res 1976;11:478-507.
4. Kaplan RM, Bush JW. Health-related Quality of Life measurement for evaluation research and policy analysis. Health Psychol 1982;1:61-80.
5. Bush JW, Chen MM, Patrick DL. Cost-effectiveness using a health status index: analysis of the New York State PKU screening program. In: Berg R, editor, Health Status Index. Chicago: Hospital Research and Educational Trust, 1973:172-208.
6. Bombadier C, Ware J, Russel U, et al Auranofin therapy and Quality of Life for patients with reumatoid arthritis: results of a multicenter trial. Am J Med 1986;8:565-78.
7. Jönsson B, Stålhammar N-O. The cost effectiveness on omeprazole and ranitidine in intermittent and maintenance treatment of reflux oesophagitis - the case of Sweden. Br J Med Econ, 1993;6:111-26.
8. Jönsson B, Drummond M F, Stålhammar N-O. Cost-effectiveness of omeprazole and ranitidine in the treatment of duodenal ulcer. PharmacoEconomics 1994;5 Suppl 3:44-55.
9. Unge P, Jönsson B, Stålhammar N-O. The cost effectiveness of Helicobacter pylori eradication versus maintenance and episodic treatment in duodenal ulcer patients in Sweden. PharmacoEconomics 1995;8(5):410-27.
10. Johannesson M, Jönsson B, Karlsson G. Outcome measurement in economic evaluation. Health Econ 1996;5:279-96.
11. Torrence GW, Furlong W, Feeny D, Boyle M. Multiattribute preference functions. Health Utilities Index. PharmacoEconomics; 1995;7:503-20.
12. Kartan B, Andersson F, Johannesson, M. The willingness to pay for a reduction in angina pectoris attacks. Med Decision-Making (in press).